Karyopharm Therapeutics(KPTI) - 2025 Q3 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K Delaware 001-36167 26-3931704 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) Newton, Massachusetts 02459 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (617) 658-0600 (Former Name or Former Address, if Changed Since Last Report) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Da ...